|
EP0948256A4
(en)
*
|
1996-10-28 |
2007-10-24 |
Univ Washington |
INDUCTION OF VIRAL MUTATIONS BY INTRODUCTION TO ERROR-CODED RIBONUCLEOSIDE ANALOGUES IN VIRAL RNA
|
|
US6887707B2
(en)
*
|
1996-10-28 |
2005-05-03 |
University Of Washington |
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
|
|
US6423695B1
(en)
*
|
1998-01-13 |
2002-07-23 |
Ribapharm, Inc. |
Cytokine related treatments of disease
|
|
JP2002540168A
(ja)
*
|
1999-03-26 |
2002-11-26 |
ウォルター リード アーミー インスティテュート オブ リサーチ |
多価デングウイルスワクチン
|
|
WO2001017518A2
(en)
*
|
1999-09-09 |
2001-03-15 |
Zymetx, Inc. |
Method of treatment of influenza
|
|
AU7938900A
(en)
*
|
1999-10-27 |
2001-05-08 |
Cytos Biotechnology Ag |
Method for creating divergent populations of nucleic acid molecules and proteins
|
|
US7638496B2
(en)
|
2000-02-15 |
2009-12-29 |
Valeant Pharmaceuticals North America |
Nucleoside analogs with carboxamidine modified monocyclic base
|
|
CN1427722A
(zh)
|
2000-02-18 |
2003-07-02 |
希拉生物化学股份有限公司 |
用核苷类似物治疗或预防黄病毒感染的方法
|
|
MY164523A
(en)
*
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
KR20080021797A
(ko)
|
2000-05-26 |
2008-03-07 |
이데닉스(케이만)리미티드 |
플라비바이러스 및 페스티바이러스의 치료방법 및 조성물
|
|
KR20090089922A
(ko)
*
|
2000-10-18 |
2009-08-24 |
파마셋 인코포레이티드 |
바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드
|
|
US8481712B2
(en)
|
2001-01-22 |
2013-07-09 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
WO2002057425A2
(en)
*
|
2001-01-22 |
2002-07-25 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
AU2002252183A1
(en)
*
|
2001-03-06 |
2002-09-19 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
|
EP1425022A4
(en)
*
|
2001-08-24 |
2009-04-29 |
Koronis Pharmaceuticals Inc |
MUTAGENIC NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF VIRAL DISEASE
|
|
JP2005536440A
(ja)
*
|
2001-09-28 |
2005-12-02 |
イデニクス（ケイマン）リミテツド |
４’位が修飾されたヌクレオシドを使用するフラビウイルスおよびペスチウイルスの治療のための方法および組成物
|
|
US7049303B2
(en)
*
|
2001-11-07 |
2006-05-23 |
Medical Research Council |
Inhibition of viruses
|
|
US20040138170A1
(en)
*
|
2002-03-06 |
2004-07-15 |
Montgomery John A. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
|
NZ537662A
(en)
*
|
2002-06-28 |
2007-10-26 |
Idenix Cayman Ltd |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
|
PL374781A1
(en)
*
|
2002-06-28 |
2005-10-31 |
Idenix (Cayman) Limited |
2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
|
WO2004011647A1
(en)
|
2002-07-26 |
2004-02-05 |
Chiron Corporation |
Modified small interfering rna molecules and methods of use
|
|
HUE033832T2
(en)
*
|
2002-11-15 |
2018-01-29 |
Idenix Pharmaceuticals Llc |
2'-methyl nucleosides in combination with interferon and Flaviviridae mutation
|
|
RU2005121904A
(ru)
*
|
2002-12-12 |
2006-01-20 |
Айденикс (Кайман) Лимитед (Ky) |
Способ получения 2`-разветвленных нуклеозидов
|
|
RU2005133093A
(ru)
*
|
2003-03-28 |
2006-07-27 |
Фармассет, Инк. (Us) |
Соединения для лечения флавивирусных инфекций
|
|
WO2005018330A1
(en)
*
|
2003-08-18 |
2005-03-03 |
Pharmasset, Inc. |
Dosing regimen for flaviviridae therapy
|
|
US20070042352A1
(en)
*
|
2003-08-18 |
2007-02-22 |
Dawn Patricia Wooley |
Retroviral vector and cell-based assay for measuring the mutations rate of retroviruses employing same
|
|
EP1858889A1
(en)
|
2005-03-08 |
2007-11-28 |
Biota Scientific Management Pty. Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
|
JP4516863B2
(ja)
*
|
2005-03-11 |
2010-08-04 |
株式会社ケンウッド |
音声合成装置、音声合成方法及びプログラム
|
|
WO2006107923A1
(en)
*
|
2005-04-05 |
2006-10-12 |
Boehringer Ingelheim International Gmbh |
Substituted benzylimidazoles useful for the treatment of inflammatory diseases
|
|
EP1976382B1
(en)
*
|
2005-12-23 |
2013-04-24 |
IDENIX Pharmaceuticals, Inc. |
Process for preparing a synthetic intermediate for preparation of branched nucleosides
|
|
EP1859690A1
(en)
|
2006-05-26 |
2007-11-28 |
Health Concern B.V. |
Premix for cholesterol lowering food products
|
|
WO2009043096A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Arana Therapeutics (Vic) Pty Ltd |
Improved method for mutagenesis
|
|
MY151004A
(en)
*
|
2007-11-29 |
2014-03-31 |
Boehringer Ingelheim Int |
Derivatives of 6,7-dihydro-5h-imidazo[1,2-?]imidazole-3-carboxylic acid amides
|
|
JP4621926B2
(ja)
*
|
2008-07-24 |
2011-02-02 |
国立大学法人九州大学 |
酵素基質修飾ヌクレオシド三リン酸、核酸プローブ、マルチラベル化核酸プローブ、マルチラベル化核酸プローブの製造方法および標的核酸の検出方法
|
|
JP5146785B2
(ja)
*
|
2008-07-24 |
2013-02-20 |
国立大学法人九州大学 |
酵素基質修飾ヌクレオシド三リン酸誘導体
|
|
AU2010226466A1
(en)
*
|
2009-03-20 |
2011-10-20 |
Alios Biopharma, Inc. |
Substituted nucleoside and nucleotide analogs
|
|
WO2010141330A1
(en)
|
2009-06-02 |
2010-12-09 |
Boehringer Ingelheim International Gmbh |
DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
|
|
EA019990B1
(ru)
|
2009-06-02 |
2014-07-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
ПРОИЗВОДНЫЕ АМИДОВ 6,7-ДИГИДРО-5H-ИМИДАЗО[1,2-a]ИМИДАЗОЛ-3-КАРБОНОВОЙ КИСЛОТЫ
|
|
JP5704481B2
(ja)
*
|
2010-01-22 |
2015-04-22 |
国立大学法人九州大学 |
核酸検出用キット
|
|
BR112013005872A2
(pt)
|
2010-09-22 |
2019-09-24 |
Alios Biopharma Inc |
compostos, composição farmacêutica e respectivos usos
|
|
WO2012142093A2
(en)
|
2011-04-13 |
2012-10-18 |
Merck Sharp & Dohme Corp. |
2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
BR112013026345A2
(pt)
|
2011-04-13 |
2019-04-24 |
Merck Sharp & Dohe Corp. |
composto, composição farmacêutica, uso de um composto, e, método para tratar um paciente infectado com hcv
|
|
WO2012142075A1
(en)
|
2011-04-13 |
2012-10-18 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
US9416154B2
(en)
|
2011-07-13 |
2016-08-16 |
Merck Sharp & Dohme Corp. |
5′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
WO2013009737A1
(en)
|
2011-07-13 |
2013-01-17 |
Merck Sharp & Dohme Corp. |
5'-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases
|
|
EP2794630A4
(en)
|
2011-12-22 |
2015-04-01 |
Alios Biopharma Inc |
SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
|
|
WO2013142124A1
(en)
|
2012-03-21 |
2013-09-26 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
|
US9012427B2
(en)
|
2012-03-22 |
2015-04-21 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
|
WO2015167616A1
(en)
*
|
2014-05-02 |
2015-11-05 |
Nitor Therapeutics |
Guanosine as an immunepotentiator mediated through toll receptors
|
|
WO2020081937A1
(en)
*
|
2018-10-19 |
2020-04-23 |
The University Of Chicago |
Methods and compositions for treating negative-sense single-stranded rna virus
|